{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:22:42Z","timestamp":1790702562562,"version":"4.1.0"},"reference-count":77,"publisher":"Rockefeller University Press","issue":"8","license":[{"start":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T00:00:00Z","timestamp":1568851200000},"content-version":"vor","delay-in-days":429,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01-AI106398"],"award-info":[{"award-number":["R01-AI106398"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01-AI111967"],"award-info":[{"award-number":["R01-AI111967"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["rupress.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,8,6]]},"abstract":"<jats:p>In the 1970s, inclusion of pyrazinamide (PZA) in the drug regimen of tuberculosis (TB) patients for the first 2 mo achieved a drastic reduction of therapy duration. Until now, however, the mechanisms underlying PZA\u2019s unique contribution to efficacy have remained controversial, and animal efficacy data vary across species. To understand how PZA kills bacterial populations present in critical lung lesion compartments, we first characterized a rabbit model of active TB, showing striking similarities in lesion types and fates to nonhuman primate models deemed the most appropriate surrogates of human TB. We next employed this model with lesion-centric molecular and bacteriology readouts to demonstrate that PZA exhibits potent activity against Mycobacterium tuberculosis residing in difficult-to-sterilize necrotic lesions. Our data also indicate that PZA is slow acting, suggesting that PZA administration beyond the first 2 mo may accelerate the cure. In conclusion, we provide a pharmacodynamic explanation for PZA\u2019s treatment-shortening effect and deliver new tools to dissect the contribution of immune response versus drug at the lesion level.<\/jats:p>","DOI":"10.1084\/jem.20180518","type":"journal-article","created":{"date-parts":[[2018,7,17]],"date-time":"2018-07-17T13:47:56Z","timestamp":1531835276000},"page":"1975-1986","update-policy":"https:\/\/doi.org\/10.1084\/jem.crossmarkpolicy","source":"Crossref","is-referenced-by-count":47,"title":["Impact of immunopathology on the antituberculous activity of pyrazinamide"],"prefix":"10.1084","volume":"215","author":[{"given":"Landry","family":"Blanc","sequence":"first","affiliation":[{"name":"Public Health Research Institute, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jansy Passiflora","family":"Sarathy","sequence":"additional","affiliation":[{"name":"Public Health Research Institute, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Alvarez Cabrera","sequence":"additional","affiliation":[{"name":"Public Health Research Institute, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"O\u2019Brien","sequence":"additional","affiliation":[{"name":"Public Health Research Institute, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1924-5097","authenticated-orcid":true,"given":"Isabela","family":"Dias-Freedman","sequence":"additional","affiliation":[{"name":"Public Health Research Institute, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marizel","family":"Mina","sequence":"additional","affiliation":[{"name":"Public Health Research Institute, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5767-2367","authenticated-orcid":true,"given":"James","family":"Sacchettini","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radojka M.","family":"Savic","sequence":"additional","affiliation":[{"name":"Department of Bioengineering and Therapeutic Sciences, Schools of Pharmacy and Medicine, University of California, San Francisco, San Francisco, CA 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0208-5920","authenticated-orcid":true,"given":"Martin","family":"Gengenbacher","sequence":"additional","affiliation":[{"name":"Public Health Research Institute, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan K.","family":"Podell","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8660-5355","authenticated-orcid":true,"given":"Brendan","family":"Prideaux","sequence":"additional","affiliation":[{"name":"Public Health Research Institute, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Ioerger","sequence":"additional","affiliation":[{"name":"Department of Computer Science, Texas A&M University, College Station, TX 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9604-9452","authenticated-orcid":true,"given":"Thomas","family":"Dick","sequence":"additional","affiliation":[{"name":"Public Health Research Institute, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ 1"},{"name":"Department of Medicine, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ 6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9470-5009","authenticated-orcid":true,"given":"V\u00e9ronique","family":"Dartois","sequence":"additional","affiliation":[{"name":"Public Health Research Institute, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ 1"},{"name":"Department of Medicine, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ 6"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"291","published-online":{"date-parts":[[2018,7,17]]},"reference":[{"key":"2023072604242389900_bib1","first-page":"276","article-title":"[Short term chemotherapy of tuberculosis. Factors affecting relapse following short term chemotherapy]","volume":"53","author":"Aber","year":"1978","journal-title":"Bull. Int. Union Tuberc."},{"key":"2023072604242389900_bib2","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1128\/AAC.01524-10","article-title":"Dose-dependent activity of pyrazinamide in animal models of intracellular and extracellular tuberculosis infections","volume":"55","author":"Ahmad","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"2023072604242389900_bib3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1164\/rccm.201212-2328OC","article-title":"Contribution of moxifloxacin or levofloxacin in second-line regimens with or without continuation of pyrazinamide in murine tuberculosis","volume":"188","author":"Ahmad","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2023072604242389900_bib4","doi-asserted-by":"publisher","first-page":"e15667","DOI":"10.1371\/journal.pone.0015667","article-title":"Simultaneous analysis of multiple Mycobacterium tuberculosis knockdown mutants in vitro and in vivo","volume":"5","author":"Blumenthal","year":"2010","journal-title":"PLoS One."},{"key":"2023072604242389900_bib5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2466-1-2","article-title":"Serial counts of Mycobacterium tuberculosis in sputum as surrogate markers of the sterilising activity of rifampicin and pyrazinamide in treating pulmonary tuberculosis","volume":"1","author":"Brindle","year":"2001","journal-title":"BMC Pulm. Med."},{"key":"2023072604242389900_bib6","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/nri.2017.69","article-title":"Heterogeneity in tuberculosis","volume":"17","author":"Cadena","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"2023072604242389900_bib7","first-page":"735","article-title":"Update: adverse event data and revised American Thoracic Society\/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection\u2013United States, 2003","volume-title":"MMWR Morb. Mortal. Wkly. Rep.","author":"Centers for Disease Control and Prevention","year":"2003"},{"key":"2023072604242389900_bib8","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1164\/rccm.200407-905OC","article-title":"A nested case-control study on treatment-related risk factors for early relapse of tuberculosis","volume":"170","author":"Chang","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2023072604242389900_bib9","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1164\/rccm.200605-637OC","article-title":"Dosing schedules of 6-month regimens and relapse for pulmonary tuberculosis","volume":"174","author":"Chang","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2023072604242389900_bib10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1128\/AAC.03931-14","article-title":"Impact of nonlinear interactions of pharmacokinetics and MICs on sputum bacillary kill rates as a marker of sterilizing effect in tuberculosis","volume":"59","author":"Chigutsa","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"2023072604242389900_bib11","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1126\/scitranslmed.3009500","article-title":"PET\/CT imaging reveals a therapeutic response to oxazolidinones in macaques and humans with tuberculosis","volume":"6","author":"Coleman","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"2023072604242389900_bib12","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3109\/17453675009043416","article-title":"Examination of pH in tuberculous pus","volume":"20","author":"Dahl","year":"1950","journal-title":"Acta Orthop. Scand."},{"key":"2023072604242389900_bib13","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1093\/infdis\/jiw313","article-title":"Relationship between HIV coinfection, interleukin 10 production, and Mycobacterium tuberculosis in human lymph node granulomas","volume":"214","author":"Diedrich","year":"2016","journal-title":"J. Infect. Dis."},{"key":"2023072604242389900_bib14","doi-asserted-by":"publisher","first-page":"7258","DOI":"10.1128\/AAC.04028-14","article-title":"Pantothenate and pantetheine antagonize the antitubercular activity of pyrazinamide","volume":"58","author":"Dillon","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"2023072604242389900_bib15","first-page":"1079","article-title":"Controlled clinical trial of short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis","volume":"1","author":"East African\/British Medical Research Councils","year":"1972","journal-title":"Lancet."},{"key":"2023072604242389900_bib16","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1378\/chest.09-0903","article-title":"Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB","volume":"137","author":"Eum","year":"2010","journal-title":"Chest."},{"key":"2023072604242389900_bib17","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/ng.811","article-title":"Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection","volume":"43","author":"Ford","year":"2011","journal-title":"Nat. Genet."},{"issue":"10","key":"2023072604242389900_bib18","first-page":"S231","article-title":"Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications","volume":"3","author":"Fox","year":"1999","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"2023072604242389900_bib19","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1021\/acsinfecdis.6b00070","article-title":"Pyrazinamide resistance is caused by two distinct mechanisms: Prevention of coenzyme A depletion and loss of virulence factor synthesis","volume":"2","author":"Gopal","year":"2016","journal-title":"ACS Infect. Dis."},{"key":"2023072604242389900_bib20","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1021\/acsinfecdis.7b00079","article-title":"Pyrazinoic acid inhibits mycobacterial coenzyme a biosynthesis by binding to aspartate decarboxylase PanD","volume":"3","author":"Gopal","year":"2017","journal-title":"ACS Infect. Dis."},{"key":"2023072604242389900_bib21","doi-asserted-by":"publisher","first-page":"e17550","DOI":"10.1371\/journal.pone.0017550","article-title":"Location of intra- and extracellular M. tuberculosis populations in lungs of mice and guinea pigs during disease progression and after drug treatment","volume":"6","author":"Hoff","year":"2011","journal-title":"PLoS One."},{"key":"2023072604242389900_bib22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0041-3879(82)80044-5","article-title":"Controlled trial of 4 three-times-weekly regimens and a daily regimen all given for 6 months for pulmonary tuberculosis. Second report: the results up to 24 months. Hong Kong Chest Service\/British Medical Research Council","volume":"63","author":"Hong Kong Chest Service\/British Medical Research Council","year":"1982","journal-title":"Tubercle."},{"key":"2023072604242389900_bib23","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.1128\/JB.00166-10","article-title":"Variation among genome sequences of H37Rv strains of Mycobacterium tuberculosis from multiple laboratories","volume":"192","author":"Ioerger","year":"2010","journal-title":"J. Bacteriol."},{"key":"2023072604242389900_bib24","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1242\/dmm.019570","article-title":"Presence of multiple lesion types with vastly different microenvironments in C3HeB\/FeJ mice following aerosol infection with Mycobacterium tuberculosis","volume":"8","author":"Irwin","year":"2015","journal-title":"Dis. Model. Mech."},{"key":"2023072604242389900_bib25","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1021\/acsinfecdis.5b00127","article-title":"Bedaquiline and pyrazinamide treatment responses are affected by pulmonary lesion heterogeneity in Mycobacterium tuberculosis infected C3HeB\/FeJ mice","volume":"2","author":"Irwin","year":"2016","journal-title":"ACS Infect. Dis."},{"key":"2023072604242389900_bib26","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1164\/rccm.200210-1125OC","article-title":"Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days","volume":"167","author":"Jindani","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2023072604242389900_bib27","doi-asserted-by":"publisher","first-page":"e00226-17","DOI":"10.1128\/AAC.00226-17","article-title":"Lung tissue concentrations of pyrazinamide among patients with drug-resistant pulmonary tuberculosis","volume":"61","author":"Kempker","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"2023072604242389900_bib28","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/BF01779121","article-title":"Nekrose und Autolyse. Beitrag zur Kenntnis der Dystrophischen Verkalkung","volume":"43","author":"Koller","year":"1934","journal-title":"Klin. Wochenschr."},{"key":"2023072604242389900_bib29","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1128\/AAC.02637-15","article-title":"Sterilizing activity of pyrazinamide in combination with first-line drugs in a C3HeB\/FeJ mouse model of tuberculosis","volume":"60","author":"Lanoix","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"2023072604242389900_bib30","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1128\/AAC.01370-15","article-title":"Selective inactivity of pyrazinamide against tuberculosis in C3HeB\/FeJ mice is best explained by neutral pH of caseum","volume":"60","author":"Lanoix","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"2023072604242389900_bib31","doi-asserted-by":"publisher","first-page":"4197","DOI":"10.1128\/AAC.03085-15","article-title":"High systemic exposure of pyrazinoic acid has limited anti-tuberculosis activity in murine and rabbit models of tuberculosis","volume":"60","author":"Lanoix","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"2023072604242389900_bib32","doi-asserted-by":"publisher","first-page":"3338","DOI":"10.1128\/AAC.00276-07","article-title":"Location of persisting mycobacteria in a Guinea pig model of tuberculosis revealed by r207910","volume":"51","author":"Lenaerts","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"2023072604242389900_bib33","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/imr.12252","article-title":"Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses","volume":"264","author":"Lenaerts","year":"2015","journal-title":"Immunol. Rev."},{"key":"2023072604242389900_bib34","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics."},{"key":"2023072604242389900_bib35","doi-asserted-by":"publisher","first-page":"4631","DOI":"10.1128\/IAI.00592-09","article-title":"Quantitative comparison of active and latent tuberculosis in the cynomolgus macaque model","volume":"77","author":"Lin","year":"2009","journal-title":"Infect. Immun."},{"key":"2023072604242389900_bib36","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nm.3412","article-title":"Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing","volume":"20","author":"Lin","year":"2014","journal-title":"Nat. Med."},{"key":"2023072604242389900_bib37","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.it.2011.10.003","article-title":"Neutrophils in tuberculosis: friend or foe?","volume":"33","author":"Lowe","year":"2012","journal-title":"Trends Immunol."},{"key":"2023072604242389900_bib38","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/nm.4177","article-title":"Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure","volume":"22","author":"Malherbe","year":"2016","journal-title":"Nat. Med."},{"key":"2023072604242389900_bib39","doi-asserted-by":"publisher","first-page":"6004","DOI":"10.1128\/IAI.71.10.6004-6011.2003","article-title":"Different strains of Mycobacterium tuberculosis cause various spectrums of disease in the rabbit model of tuberculosis","volume":"71","author":"Manabe","year":"2003","journal-title":"Infect. Immun."},{"key":"2023072604242389900_bib40","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nm.4073","article-title":"Inflammatory signaling in human tuberculosis granulomas is spatially organized","volume":"22","author":"Marakalala","year":"2016","journal-title":"Nat. Med."},{"key":"2023072604242389900_bib41","doi-asserted-by":"publisher","first-page":"e00312-17","DOI":"10.1128\/mBio.00312-17","article-title":"Digitally barcoding Mycobacterium tuberculosis reveals in vivo infection dynamics in the macaque model of tuberculosis","volume":"8","author":"Martin","year":"2017","journal-title":"MBio."},{"key":"2023072604242389900_bib42","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1084\/jem.104.5.737","article-title":"Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. I. The persistence of drug-susceptible tubercle bacilli in the tissues despite prolonged antimicrobial therapy","volume":"104","author":"McCune","year":"1956","journal-title":"J. Exp. Med."},{"key":"2023072604242389900_bib43","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1084\/jem.104.5.763","article-title":"The fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. II. The conversion of tuberculous infection to the latent state by the administration of pyrazinamide and a companion drug","volume":"104","author":"McCune","year":"1956","journal-title":"J. Exp. Med."},{"key":"2023072604242389900_bib44","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1084\/jem.123.3.445","article-title":"Microbial persistence. I. The capacity of tubercle bacilli to survive sterilization in mouse tissues","volume":"123","author":"McCune","year":"1966","journal-title":"J. Exp. Med."},{"key":"2023072604242389900_bib45","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1084\/jem.123.3.469","article-title":"Microbial persistence. II. Characteristics of the sterile state of tubercle bacilli","volume":"123","author":"McCune","year":"1966","journal-title":"J. Exp. Med."},{"key":"2023072604242389900_bib46","first-page":"748","article-title":"Activation of pyrazinamide and nicotinamide in acidic environments in vitro","volume":"70","author":"McDermott","year":"1954","journal-title":"Am. Rev. Tuberc."},{"key":"2023072604242389900_bib47","doi-asserted-by":"publisher","first-page":"17072","DOI":"10.1038\/nmicrobiol.2017.72","article-title":"Nitric oxide prevents a pathogen-permissive granulocytic inflammation during tuberculosis","volume":"2","author":"Mishra","year":"2017","journal-title":"Nat. Microbiol."},{"key":"2023072604242389900_bib48","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0041-3879(85)90040-6","article-title":"The action of antituberculosis drugs in short-course chemotherapy","volume":"66","author":"Mitchison","year":"1985","journal-title":"Tubercle."},{"key":"2023072604242389900_bib49","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1055\/s-2004-829503","article-title":"Antimicrobial therapy of tuberculosis: justification for currently recommended treatment regimens","volume":"25","author":"Mitchison","year":"2004","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"2023072604242389900_bib50","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.2741\/1293","article-title":"The search for new sterilizing anti-tuberculosis drugs","volume":"9","author":"Mitchison","year":"2004","journal-title":"Front. Biosci."},{"key":"2023072604242389900_bib51","doi-asserted-by":"publisher","first-page":"5420","DOI":"10.1128\/AAC.00928-10","article-title":"Activity of pyrazinamide in the guinea pig model of tuberculosis","volume":"54","author":"Mitchison","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"2023072604242389900_bib52","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nm1252","article-title":"Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence","volume":"11","author":"Mu\u00f1oz-El\u00edas","year":"2005","journal-title":"Nat. Med."},{"key":"2023072604242389900_bib53","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1128\/IAI.73.1.546-551.2005","article-title":"Replication dynamics of Mycobacterium tuberculosis in chronically infected mice","volume":"73","author":"Mu\u00f1oz-El\u00edas","year":"2005","journal-title":"Infect. Immun."},{"key":"2023072604242389900_bib54","doi-asserted-by":"publisher","first-page":"eaan6195","DOI":"10.1126\/scitranslmed.aan6195","article-title":"Neutrophils: Double agents for TB","volume":"9","author":"Philips","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"2023072604242389900_bib55","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/nm.3937","article-title":"The association between sterilizing activity and drug distribution into tuberculosis lesions","volume":"21","author":"Prideaux","year":"2015","journal-title":"Nat. Med."},{"key":"2023072604242389900_bib56","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1128\/AAC.32.7.1002","article-title":"Determination of pyrazinamide MICs for Mycobacterium tuberculosis at different pHs by the radiometric method","volume":"32","author":"Salfinger","year":"1988","journal-title":"Antimicrob. Agents Chemother."},{"key":"2023072604242389900_bib57","doi-asserted-by":"publisher","first-page":"e02266-17","DOI":"10.1128\/AAC.02266-17","article-title":"Extreme drug tolerance of Mycobacterium tuberculosis in caseum","volume":"62","author":"Sarathy","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"2023072604242389900_bib58","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/cpt.634","article-title":"Defining the optimal dose of rifapentine for pulmonary tuberculosis: Exposure-response relations from two phase II clinical trials","volume":"102","author":"Savic","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"key":"2023072604242389900_bib59","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.vetmic.2010.02.024","article-title":"Distribution of Mycobacterium avium subsp. avium and M. a. hominissuis in artificially infected pigs studied by culture and IS901 and IS1245 quantitative real time PCR","volume":"144","author":"Slana","year":"2010","journal-title":"Vet. Microbiol."},{"key":"2023072604242389900_bib60","doi-asserted-by":"publisher","first-page":"110016","DOI":"10.1098\/rsob.110016","article-title":"Chronic pulmonary cavitary tuberculosis in rabbits: a failed host immune response","volume":"1","author":"Subbian","year":"2011","journal-title":"Open Biol."},{"key":"2023072604242389900_bib61","doi-asserted-by":"publisher","first-page":"e1004394","DOI":"10.1371\/journal.ppat.1004394","article-title":"Exploitation of Mycobacterium tuberculosis reporter strains to probe the impact of vaccination at sites of infection","volume":"10","author":"Sukumar","year":"2014","journal-title":"PLoS Pathog."},{"key":"2023072604242389900_bib62","doi-asserted-by":"publisher","first-page":"3664","DOI":"10.1128\/AAC.00686-08","article-title":"Enhanced bactericidal activity of rifampin and\/or pyrazinamide when combined with PA-824 in a murine model of tuberculosis","volume":"52","author":"Tasneen","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"2023072604242389900_bib63","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/0041-3879(81)90016-7","article-title":"Clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis: the results up to 30 months","volume":"62","author":"Tuberculosis Service\/British Medical Research Council","year":"1981","journal-title":"Tubercle."},{"key":"2023072604242389900_bib64","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1128\/jcm.29.11.2578-2586.1991","article-title":"Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis","volume":"29","author":"van Soolingen","year":"1991","journal-title":"J. Clin. Microbiol."},{"key":"2023072604242389900_bib65","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.1128\/AAC.00531-12","article-title":"Infection dynamics and response to chemotherapy in a rabbit model of tuberculosis using [18F]2-fluoro-deoxy-D-glucose positron emission tomography and computed tomography","volume":"56","author":"Via","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"2023072604242389900_bib66","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1128\/IAI.00632-13","article-title":"Differential virulence and disease progression following Mycobacterium tuberculosis complex infection of the common marmoset (Callithrix jacchus)","volume":"81","author":"Via","year":"2013","journal-title":"Infect. Immun."},{"key":"2023072604242389900_bib67","doi-asserted-by":"publisher","first-page":"4181","DOI":"10.1128\/AAC.00115-15","article-title":"A sterilizing tuberculosis treatment regimen is associated with faster clearance of bacteria in cavitary lesions in marmosets","volume":"59","author":"Via","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"2023072604242389900_bib68","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1021\/id500028m","article-title":"Host-mediated bioactivation of pyrazinamide: Implications for efficacy, resistance, and therapeutic alternatives","volume":"1","author":"Via","year":"2015","journal-title":"ACS Infect. Dis."},{"key":"2023072604242389900_bib69","first-page":"161","article-title":"Local tissue hyperacidification and lysosomes","volume":"48","author":"von Ardenne","year":"1979","journal-title":"Front. Biol."},{"key":"2023072604242389900_bib70","doi-asserted-by":"publisher","first-page":"e1002287","DOI":"10.1371\/journal.ppat.1002287","article-title":"Fumarate reductase activity maintains an energized membrane in anaerobic Mycobacterium tuberculosis","volume":"7","author":"Watanabe","year":"2011","journal-title":"PLoS Pathog."},{"key":"2023072604242389900_bib71","first-page":"179","article-title":"Mechanism of softening of tubercles. III. Hydrolysis of protein and nucleic acid during anaerobic autolysis of normal and tuberculous lung tissue in vitro","volume":"57","author":"Weiss","year":"1954","journal-title":"AMA Arch. Pathol."},{"key":"2023072604242389900_bib72","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00228-006-0141-z","article-title":"Variability in the population pharmacokinetics of pyrazinamide in South African tuberculosis patients","volume":"62","author":"Wilkins","year":"2006","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"2023072604242389900_bib73","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1128\/AAC.00384-12","article-title":"Sterilizing activities of novel combinations lacking first- and second-line drugs in a murine model of tuberculosis","volume":"56","author":"Williams","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"2023072604242389900_bib74","author":"World Health Organization","year":"2017"},{"key":"2023072604242389900_bib75","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1128\/JB.181.7.2044-2049.1999","article-title":"Role of acid pH and deficient efflux of pyrazinoic acid in unique susceptibility of Mycobacterium tuberculosis to pyrazinamide","volume":"181","author":"Zhang","year":"1999","journal-title":"J. Bacteriol."},{"key":"2023072604242389900_bib76","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1099\/0022-1317-51-1-42","article-title":"Conditions that may affect the results of susceptibility testing of Mycobacterium tuberculosis to pyrazinamide","volume":"51","author":"Zhang","year":"2002","journal-title":"J. Med. Microbiol."},{"key":"2023072604242389900_bib77","doi-asserted-by":"publisher","first-page":"e00924-17","DOI":"10.1128\/AAC.00924-17","article-title":"Ethambutol partitioning in tuberculous pulmonary lesions explains its clinical efficacy","volume":"61","author":"Zimmerman","year":"2017","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/215\/8\/1975\/1760028\/jem_20180518.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/215\/8\/1975\/1760028\/jem_20180518.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T04:25:23Z","timestamp":1690345523000},"score":1,"resource":{"primary":{"URL":"https:\/\/rupress.org\/jem\/article\/215\/8\/1975\/46042\/Impact-of-immunopathology-on-the-antituberculous"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,17]]},"references-count":77,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8,6]]}},"URL":"https:\/\/doi.org\/10.1084\/jem.20180518","relation":{},"ISSN":["0022-1007","1540-9538"],"issn-type":[{"value":"0022-1007","type":"print"},{"value":"1540-9538","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,17]]}}}